Hugo Mouquet

Title: Hugo Mouquet: Innovator in Monoclonal Antibodies

Introduction

Hugo Mouquet is a prominent inventor based in Paris, France. He is known for his significant contributions to the field of immunology, particularly in the development of monoclonal antibodies. His work has been pivotal in addressing critical health challenges, including the COVID-19 pandemic.

Latest Patents

Hugo Mouquet holds a patent for "Broadly SARS-CoV-2 neutralizing monoclonal antibodies and uses thereof." This invention relates to antibodies against Severe Acute Respiratory Syndrome-related Coronavirus 2 (SARS-CoV-2). Specifically, it focuses on human neutralizing monoclonal antibodies that possess a broad neutralization spectrum. These antibodies are essential for the diagnosis, monitoring, prevention, and treatment of SARS-CoV-2 infection and the associated disease, COVID-19. He has 1 patent to his name.

Career Highlights

Throughout his career, Hugo Mouquet has worked with esteemed organizations such as Institut Pasteur and Spikimm. His research has significantly advanced the understanding of viral infections and the development of therapeutic strategies.

Collaborations

Hugo has collaborated with notable colleagues, including Cyril Planchais and Antoine Pau. Their joint efforts have contributed to the progress in the field of monoclonal antibodies and their applications in combating viral diseases.

Conclusion

Hugo Mouquet's innovative work in the development of monoclonal antibodies has made a substantial impact on public health, particularly in the fight against COVID-19. His contributions continue to shape the future of immunological research and therapeutic interventions.